CN101016283A - 喷雾干燥法制备炎琥宁 - Google Patents

喷雾干燥法制备炎琥宁 Download PDF

Info

Publication number
CN101016283A
CN101016283A CN 200710008665 CN200710008665A CN101016283A CN 101016283 A CN101016283 A CN 101016283A CN 200710008665 CN200710008665 CN 200710008665 CN 200710008665 A CN200710008665 A CN 200710008665A CN 101016283 A CN101016283 A CN 101016283A
Authority
CN
China
Prior art keywords
potassium sodium
dehydroandroan drographolide
sodium dehydroandroan
reaction soln
drographolide succinate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN 200710008665
Other languages
English (en)
Other versions
CN101016283B (zh
Inventor
汪旗
李传标
乐运焱
吴晓华
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujian Mindong lijiexin Pharmaceutical Co.,Ltd.
Original Assignee
FUZHOU JUYING PHARMACEUTICAL Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by FUZHOU JUYING PHARMACEUTICAL Co Ltd filed Critical FUZHOU JUYING PHARMACEUTICAL Co Ltd
Priority to CN2007100086657A priority Critical patent/CN101016283B/zh
Publication of CN101016283A publication Critical patent/CN101016283A/zh
Application granted granted Critical
Publication of CN101016283B publication Critical patent/CN101016283B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

本发明提供一种药品原料药炎琥宁(14-脱羟-11,12-二脱氢穿心莲内酯-3,19-二琥珀酸半酯钾钠盐)的制备方法,包括炎琥宁反应溶液的制备,本发明是对炎琥宁反应溶液的固化过程进行改进,将炎琥宁反应溶液加入喷雾干燥器进行喷雾干燥制得炎琥宁成品,所述喷雾干燥的条件为进风温度80~160℃,雾化频率300.0~1000.0rpm,出风温度50~100℃时,蠕动泵转速10~40rpm。本发明方法生产的产品不需要使用丙酮、乙酸乙酯等有机溶剂,具有收率高、纯度好的优点。

Description

喷雾干燥法制备炎琥宁
技术领域
本发明涉及一种药品原料药炎琥宁(14-脱羟-11,12-二脱氢穿心莲内酯-3,19-二琥珀酸半酯钾钠盐)的制备方法的改进。
背景技术
炎琥宁(14-脱羟-11,12-二脱氢穿心莲内酯-3,19-二琥珀酸半酯钾钠盐)为淡黄色粉末,具有清热解毒及抗病毒作用,临床上主要用于病毒性肺炎和病毒性上呼吸道感染。期刊杂志以及专利均有报道该产品的结晶制备方法,但其方法是使用溶媒结晶的方法获得本产品,缺点在于结晶过程中使用大量的丙酮进行结晶,必要时还需使用乙酸乙酯浸泡,产品颜色较深且收率低。
发明内容
本发明的目的是针对上述问题,提供一种喷雾干燥法制备炎琥宁,本制备方法不需溶媒结晶方法分离、纯化,制得的成品具有收率高、纯度好的优点。
本发明的喷雾干燥法制备炎琥宁,包括炎琥宁反应溶液的制备,是对炎琥宁反应溶液的固化过程进行改进,所述改进为:将炎琥宁反应溶液加入喷雾干燥器进行喷雾干燥制得炎琥宁成品,所述喷雾干燥的条件为进风温度80~160℃,雾化频率300.0~1000.0rpm,出风温度50~100℃时,蠕动泵转速10~40rpm。
本发明的显著优点是:
1)不需要通过溶媒结晶方法分离、纯化就可以得到炎琥宁成品,制备成品的收率高;
2)炎琥宁成品不包含的丙酮、乙酸乙酯有机溶剂残留成分,纯度高。
具体实施方式
将炎琥宁反应溶液加入喷雾干燥器物料斗,设置好进风温度80~160℃,雾化频率300.0~1000.0rpm开启喷雾干燥机,启动引风机,开始加热,待进风温度达到80~160℃,并且出风温度达到50~100℃时,开启雾化和蠕动泵,进行喷雾干燥,控制好蠕动泵的转速10~40rpm使出风相对稳定在50~100℃之间,喷雾干燥好的物料装桶制得炎琥宁成品。
炎琥宁反应溶液可以是穿琥宁作为反应起始物制备炎琥宁的反应溶液,也可以是以其他中间体为反应起始物来制备炎琥宁的反应溶液。
实施例1
将10Kg穿琥宁置反应罐中,加95%乙醇,开启搅拌机,缓慢加入与穿琥宁等摩尔的碳酸钠溶液,搅拌溶液澄清,再加入处方量(反应体积的0.1%-0.5%)活性炭脱色30min,过滤,得到炎琥宁反应溶液。
过滤好的炎琥宁反应溶液加入物料斗,设置好进风温度110℃,雾化频率800.0rpm开启喷雾干燥机,开启引风机,开始加热,待进风温度达到120℃,并且出风温度达到90℃时,开启雾化和蠕动泵,进行喷雾干燥,控制好蠕动泵的流速24~27rpm使出风相对稳定在75-80℃之间,将喷雾干燥好的物料装桶即得,得成品10.2Kg,收率102%。
实施例2
将10Kg穿琥宁置反应罐中,加95%乙醇,开启搅拌机,缓慢加入与穿琥宁等摩尔的碳酸氢钠、碳酸氢钾溶液,搅拌溶液澄清,再加入处方量(反应体积的0.1%-0.5%)活性炭脱色30min,过滤,得到炎琥宁反应溶液。
过滤好的炎琥宁反应溶液加入物料斗,设置好进风温度130℃,雾化频率500.0rpm开启喷雾干燥机,开启引风机,开始加热,待进风温度达到125℃,并且出风温度达到90℃时,开启雾化和蠕动泵,进行喷雾干燥,控制好蠕动泵的流速28~30rpm使出风相对稳定在80-82℃之间,将喷雾干燥好的物料装桶即得,得成品9.9Kg,收率99%。
实施例3
将10Kg穿琥宁反应中间体14-脱羟-11,12-二脱氢穿心莲内酯-3,19-二琥珀酸半酯置反应罐中,加95%乙醇,开启搅拌机,缓慢加入与穿琥宁等摩尔碳酸钠、碳酸氢钾溶液,搅拌溶液澄清,再加入处方量(反应体积的0.1%-0.5%)活性炭脱色30min,过滤,得到炎琥宁反应溶液。
过滤好的炎琥宁反应溶液加入物料斗,设置好进风温度110℃,雾化频率800.0rpm开启喷雾干燥机,开启引风机,开始加热,待进风温度达到120℃,并且出风温度达到90℃时,开启雾化和蠕动泵,进行喷雾干燥,控制好蠕动泵的流速24~27rpm使出风相对稳定在75-80℃之间,将喷雾干燥好的物料装桶即得,得成品9.56Kg,收率95.6%。

Claims (3)

1.一种喷雾干燥法制备炎琥宁,即14-脱羟-11,12-二脱氢穿心莲内酯-3,19-二琥珀酸半酯钾钠盐,包括炎琥宁反应溶液的制备,其特征在于:对炎琥宁反应溶液的固化过程进行改进,所述改进为:将炎琥宁反应溶液加入喷雾干燥器进行喷雾干燥制得炎琥宁成品,所述喷雾干燥的条件为进风温度80~160℃,雾化频率300.0~1000.0rpm,出风温度50~100℃,蠕动泵转速10~40rpm。
2.根据权利要求1所述的喷雾干燥法制备炎琥宁,其特征在于:所述改进的步骤为:将炎琥宁反应溶液加入喷雾干燥器物料斗,设置好进风温度80~160℃,雾化频率300.0~1000.0rpm开启喷雾干燥机,启动引风机,开始加热,待进风温度达到80~160℃,并且出风温度达到50~100℃时,开启雾化和蠕动泵,进行喷雾干燥,控制好蠕动泵的转速10~40rpm使出风相对稳定在50~100℃之间,喷雾干燥好的物料装桶制得炎琥宁成品。
3.根据权利要求1所述的喷雾干燥法制备炎琥宁,其特征在于:所述炎琥宁反应溶液是穿琥宁作为反应起始物制备炎琥宁的反应溶液或是以其他中间体为反应起始物来制备炎琥宁的反应溶液。
CN2007100086657A 2007-03-07 2007-03-07 喷雾干燥法制备炎琥宁 Active CN101016283B (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2007100086657A CN101016283B (zh) 2007-03-07 2007-03-07 喷雾干燥法制备炎琥宁

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2007100086657A CN101016283B (zh) 2007-03-07 2007-03-07 喷雾干燥法制备炎琥宁

Publications (2)

Publication Number Publication Date
CN101016283A true CN101016283A (zh) 2007-08-15
CN101016283B CN101016283B (zh) 2010-07-28

Family

ID=38725524

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2007100086657A Active CN101016283B (zh) 2007-03-07 2007-03-07 喷雾干燥法制备炎琥宁

Country Status (1)

Country Link
CN (1) CN101016283B (zh)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008098329A2 (en) * 2007-02-13 2008-08-21 Aché Laboratórios Farmacêuticos S/A Pharmaceutical composition, pharmaceutical product, obtaining processes of pharmaceutical compounds and use of such compounds for treating erectile dysfunction
CN104570813A (zh) * 2013-10-25 2015-04-29 仲兆准 喷雾干燥仪集成控制器
CN104744412A (zh) * 2015-04-07 2015-07-01 重庆药友制药有限责任公司 一种炎琥宁化合物

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008098329A2 (en) * 2007-02-13 2008-08-21 Aché Laboratórios Farmacêuticos S/A Pharmaceutical composition, pharmaceutical product, obtaining processes of pharmaceutical compounds and use of such compounds for treating erectile dysfunction
WO2008098329A3 (en) * 2007-02-13 2009-02-05 Ache Lab Farmaceuticos Sa Pharmaceutical composition, pharmaceutical product, obtaining processes of pharmaceutical compounds and use of such compounds for treating erectile dysfunction
CN104570813A (zh) * 2013-10-25 2015-04-29 仲兆准 喷雾干燥仪集成控制器
CN104744412A (zh) * 2015-04-07 2015-07-01 重庆药友制药有限责任公司 一种炎琥宁化合物

Also Published As

Publication number Publication date
CN101016283B (zh) 2010-07-28

Similar Documents

Publication Publication Date Title
CN102584752B (zh) 一种炎琥宁原料药制备方法
CN110563600B (zh) 一种磷酸奥司他韦的制备方法
CN101016283B (zh) 喷雾干燥法制备炎琥宁
CN103420881B (zh) 一种新的药用消旋羟蛋氨酸钙的制备方法
CN108586360B (zh) 一种6-氯-3-甲基尿嘧啶的制备方法
CN107698578A (zh) 一种噻虫嗪的制备方法
CN100497309C (zh) 杂芳环缩氨基硫脲类抗肿瘤药物的合成方法
WO2016127890A1 (zh) 一种草甘膦农药活性组合物及其制备方法
CN103087017A (zh) 炎琥宁粗品精制方法
CN104844593A (zh) 一种阿哌沙班药物中间体的合成方法
CN104744390A (zh) 一种依折麦布中间体酮的制备方法
CN103113330A (zh) 炎琥宁成盐工艺
CN111848535B (zh) 一种合成1h-四氮唑乙酸的工艺
CN107383062A (zh) 头孢布烯母核7‑ance的制备方法
CN107892676A (zh) 头孢地尼活性硫酯的制备方法
CN114702425A (zh) (s)-2-氨基-(s)-3-[吡咯烷酮-2’]丙氨酸衍生物及中间体的制备方法
CN103145639A (zh) 2-甲基-4-(三氟甲基)噻唑-5-甲酸的制备方法
CN106565621A (zh) 一种异噁唑草酮的合成方法
CN101824004B (zh) 一种头孢布烯侧链的合成工艺
CN110922345B (zh) 一种福多司坦的合成方法
CN104151275A (zh) 炎琥宁化合物的制备方法
CN110452165B (zh) 一种2-甲基吡啶-4-甲酸的制备方法
CN113788750B (zh) 一种苯氧乙酸钠的制备方法
CN103910695B (zh) 一种非布索坦的合成方法
CN112028838B (zh) 一种2-乙氧基-5-氟尿嘧啶杂质的制备方法

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
EE01 Entry into force of recordation of patent licensing contract

Assignee: Fujian Mindong Rejuvenation Pharmaceutical Co., Ltd.

Assignor: Fuzhou Juying Pharmaceutical Co., Ltd.

Contract record no.: 2010350000200

Denomination of invention: Preparation of tanhuning

Granted publication date: 20100728

License type: Exclusive License

Open date: 20070815

Record date: 20100825

DD01 Delivery of document by public notice

Addressee: Fuzhou Juying Pharmaceutical Co., Ltd.

Document name: Notification that Application Deemed not to be Proposed

ASS Succession or assignment of patent right

Owner name: MINDONG LIJIEXUN PHARMACEUTICAL CO., LTD., FUJIAN

Free format text: FORMER OWNER: FUZHOU JUYING PHARMACEUTICAL CO., LTD.

Effective date: 20130305

C41 Transfer of patent application or patent right or utility model
COR Change of bibliographic data

Free format text: CORRECT: ADDRESS; FROM: 350007 FUZHOU, FUJIAN PROVINCE TO: 355300 NINGDE, FUJIAN PROVINCE

TR01 Transfer of patent right

Effective date of registration: 20130305

Address after: 355300 pharmaceutical industry zone (Lower Village), Zherong County, Fujian, Ningde

Patentee after: Fujian Mindong Rejuvenation Pharmaceutical Co., Ltd.

Address before: 350007 Fujian city in Fuzhou Province, Hongshan Road No. 68 building 6 Shida Technology City A

Patentee before: Fuzhou Juying Pharmaceutical Co., Ltd.

CP03 Change of name, title or address
CP03 Change of name, title or address

Address after: 355300 No.1 pharmaceutical industry road, Zherong County, Ningde City, Fujian Province

Patentee after: Fujian Mindong lijiexin Pharmaceutical Co.,Ltd.

Address before: 355300 Pharmaceutical Industrial Park (Xiacun), Zherong County, Ningde City, Fujian Province

Patentee before: Fujian Mindong Rejuvenation Pharmaceutical Co.,Ltd.